ConductScience.org, home

Paper1283370

Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia.

Beisland HO and 9 others. Eur Urol, 1992. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia. Papers, record 1283370. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1283370

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia.
PubMed
Journal
Eur Urol
PubMed
Year
1992
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.69
iCite
Revised in PubMed
2019-08-24
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Beisland HOH O
2Binkowitz BB
3Brekkan EE
4Ekman PP
5Kontturi MM
6Lehtonen TT
7Lundmo PP
8Pappas FF
9Round EE
10Shapiro DD

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
5-alpha Reductase InhibitorsMajor topic
AndrostenesMajor topic
AzasteroidsMajor topic
Prostatic HyperplasiaMajor topic
Adult
Aged
Aged, 80 and over
Dihydrotestosterone
Double-Blind Method
Finasteride
Follow-Up Studies
Humans
Male
Middle Aged
Osteocalcin
Prostate-Specific Antigen
Scandinavian and Nordic Countries
Testosterone
Urination

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
20927745Finasteride for benign prostatic hyperplasia.Cochrane Database Syst Rev2010https://conductscience.org/library/papers/20927745PubMed
19936164Therapeutic options in the treatment of benign prostatic hyperplasia.Patient Prefer Adherence2009https://conductscience.org/library/papers/19936164PubMed
16323969Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment options.Drugs Aging2005https://conductscience.org/library/papers/16323969PubMed
15260927The role of 5-alpha-reductase inhibition as monotherapy in view of the MTOPS data.Curr Urol Rep2004https://conductscience.org/library/papers/15260927PubMed
12962139Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats.Mol Cell Biochem2003https://conductscience.org/library/papers/12962139PubMed
12477383Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials.BMC Urol2002https://conductscience.org/library/papers/12477383PubMed
10235693Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasia.Drugs1999https://conductscience.org/library/papers/10235693PubMed
9530536A risk-benefit assessment of treatment with finasteride in benign prostatic hyperplasia.Drug Saf1998https://conductscience.org/library/papers/9530536PubMed
9144895Conservative non-instrumental treatment of benign prostatic hyperplasia.Urol Res1997https://conductscience.org/library/papers/9144895PubMed
9061268Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.Drugs Aging1997https://conductscience.org/library/papers/9061268PubMed
8911291Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.CMAJ1996https://conductscience.org/library/papers/8911291PubMed
8846625Clinical pharmacokinetics and pharmacodynamics of finasteride.Clin Pharmacokinet1996https://conductscience.org/library/papers/8846625PubMed
7691505Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia.Drugs1993https://conductscience.org/library/papers/7691505PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1283370

GET https://conductscience.org/api/papers/v1/1283370/authors